Rheumatoid Arthritis Treatment Options and Type 2 Diabetes: Unravelling the Association
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Rheumatoid Arthritis Treatment Options and Type 2 Diabetes: Unravelling the Association
Authors
Keywords
-
Journal
BIODRUGS
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-11-03
DOI
10.1007/s40259-022-00561-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Mechanistic and therapeutic links between rheumatoid arthritis and diabetes mellitus
- (2022) Jing Li et al. CLINICAL AND EXPERIMENTAL MEDICINE
- Interleukin 1 receptor antagonist relation to cardiovascular disease risk in patients with rheumatoid arthritis
- (2022) Cristina Almeida-Santiago et al. Scientific Reports
- Disease activity, cytokines, chemokines and the risk of incident diabetes in rheumatoid arthritis
- (2021) Joshua F Baker et al. ANNALS OF THE RHEUMATIC DISEASES
- Working and safety profiles of JAK/STAT signaling inhibitors. Are these small molecules also smart?
- (2021) Elvira Favoino et al. AUTOIMMUNITY REVIEWS
- Activation of Bone Marrow Adaptive Immunity in Type 2 Diabetes: Rescue by Co-stimulation Modulator Abatacept
- (2021) Marianna Santopaolo et al. Frontiers in Immunology
- Insulin Signaling in Arthritis
- (2021) Cesare Tripolino et al. Frontiers in Immunology
- Diabetes mellitus and cardiovascular risk management in patients with rheumatoid arthritis: an international audit
- (2021) Anne Grete Semb et al. RMD Open
- The relationship between rheumatoid arthritis and diabetes mellitus: a systematic review and meta-analysis
- (2021) Zixing Tian et al. Cardiovascular Endocrinology & Metabolism
- CTLA4-Ig (abatacept): a promising investigational drug for use in type 1 diabetes
- (2020) Ousama Rachid et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Methotrexate and its mechanisms of action in inflammatory arthritis
- (2020) Bruce N. Cronstein et al. Nature Reviews Rheumatology
- Sitagliptin and tofacitinib ameliorate adjuvant induced arthritis via modulating the cross talk between JAK/STAT and TLR-4/NF-κB signaling pathways
- (2020) Sherihan Salaheldin Abdelhamid Ibrahim et al. LIFE SCIENCES
- Cardiovascular risk and mortality in rheumatoid arthritis compared with diabetes mellitus and the general population
- (2020) Brian B Løgstrup et al. RHEUMATOLOGY
- Baricitinib counteracts metaflammation, thus protecting against diet-induced metabolic abnormalities in mice
- (2020) Debora Collotta et al. Molecular Metabolism
- The growing role of precision medicine for the treatment of autoimmune diseases; results of a systematic review of literature and Experts’ Consensus
- (2020) Roberto Giacomelli et al. AUTOIMMUNITY REVIEWS
- IL-1 inhibition improves insulin resistance and adipokines in rheumatoid arthritis patients with comorbid type 2 diabetes
- (2019) Piero Ruscitti et al. MEDICINE
- The effect of non-TNF-targeted biologics on vascular dysfunction in rheumatoid arthritis: A systematic literature review
- (2019) Francesco Ursini et al. AUTOIMMUNITY REVIEWS
- Anti-interleukin-1 treatment in patients with rheumatoid arthritis and type 2 diabetes (TRACK): A multicentre, open-label, randomised controlled trial
- (2019) Piero Ruscitti et al. PLOS MEDICINE
- Insulin as an immunomodulatory hormone
- (2019) Gustav van Niekerk et al. CYTOKINE & GROWTH FACTOR REVIEWS
- The effect of non–TNF-targeted biologics and small molecules on insulin resistance in inflammatory arthritis
- (2018) Francesco Ursini et al. AUTOIMMUNITY REVIEWS
- Anti-Inflammatory Therapy With Canakinumab for the Prevention and Management of Diabetes
- (2018) Brendan M. Everett et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- JAK1/JAK2 inhibition by baricitinib in diabetic kidney disease: results from a Phase 2 randomized controlled clinical trial
- (2018) Katherine R Tuttle et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Effects of tumor necrosis factor inhibitors and tocilizumab on the glycosylated hemoglobin levels in patients with rheumatoid arthritis; an observational study
- (2018) Yukimi Otsuka et al. PLoS One
- Increased cardiovascular risk in rheumatoid arthritis: mechanisms and implications
- (2018) Bryant R England et al. BMJ-British Medical Journal
- Increased cardiovascular risk in rheumatoid arthritis: mechanisms and implications
- (2018) Bryant R England et al. BMJ-British Medical Journal
- Guidelines for biomarkers in autoimmune rheumatic diseases - evidence based analysis
- (2018) Roberto Giacomelli et al. AUTOIMMUNITY REVIEWS
- Elevated circulating effector memory T cells but similar levels of regulatory T cells in patients with type 2 diabetes mellitus and cardiovascular disease
- (2018) Sara Rattik et al. Diabetes & Vascular Disease Research
- Cardiovascular and Metabolic Comorbidities in Rheumatoid Arthritis
- (2018) Silvio Romano et al. Current Rheumatology Reports
- Rheumatoid arthritis, insulin resistance, and diabetes
- (2017) Julia Nicolau et al. JOINT BONE SPINE
- Tumor Necrosis Factor-Alpha: Role in Development of Insulin Resistance and Pathogenesis of Type 2 Diabetes Mellitus
- (2017) Muhammad Sajid Hamid Akash et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Novel treatment strategies in rheumatoid arthritis
- (2017) Gerd R Burmester et al. LANCET
- Prevalence of type 2 diabetes and impaired fasting glucose in patients affected by rheumatoid arthritis
- (2017) Piero Ruscitti et al. MEDICINE
- Inflammation, metaflammation and immunometabolic disorders
- (2017) Gökhan S. Hotamisligil NATURE
- Biochemical and cellular properties of insulin receptor signalling
- (2017) Rebecca A. Haeusler et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
- (2017) Paul M Ridker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Poor clinical response in rheumatoid arthritis is the main risk factor for diabetes development in the short-term: A 1-year, single-centre, longitudinal study
- (2017) Piero Ruscitti et al. PLoS One
- Selected cytokine pathways in rheumatoid arthritis
- (2017) Mélissa Noack et al. Seminars in Immunopathology
- Changes in body composition and metabolic profile during interleukin 6 inhibition in rheumatoid arthritis
- (2017) Anne Tournadre et al. Journal of Cachexia Sarcopenia and Muscle
- Sarilumab and Nonbiologic Disease-Modifying Antirheumatic Drugs in Patients With Active Rheumatoid Arthritis and Inadequate Response or Intolerance to Tumor Necrosis Factor Inhibitors
- (2017) Roy Fleischmann et al. Arthritis & Rheumatology
- Defining conditions where long-term glucocorticoid treatment has an acceptably low level of harm to facilitate implementation of existing recommendations: viewpoints from an EULAR task force
- (2016) Cindy Strehl et al. ANNALS OF THE RHEUMATIC DISEASES
- Risk of diabetes mellitus associated with disease-modifying antirheumatic drugs and statins in rheumatoid arthritis
- (2016) Gulsen Ozen et al. ANNALS OF THE RHEUMATIC DISEASES
- Efficacy and safety of sarilumab monotherapy versus adalimumab monotherapy for the treatment of patients with active rheumatoid arthritis (MONARCH): a randomised, double-blind, parallel-group phase III trial
- (2016) Gerd R Burmester et al. ANNALS OF THE RHEUMATIC DISEASES
- Multiple benefits of targeting inflammation in the treatment of type 2 diabetes
- (2016) Marc Y. Donath DIABETOLOGIA
- IL-1β at the crossroad between rheumatoid arthritis and type 2 diabetes: may we kill two birds with one stone?
- (2016) Roberto Giacomelli et al. Expert Review of Clinical Immunology
- The JAK/STAT pathway in obesity and diabetes
- (2016) Esteban N. Gurzov et al. FEBS Journal
- Rheumatoid arthritis
- (2016) Josef S Smolen et al. LANCET
- Sitagliptin attenuates cardiomyopathy by modulating the JAK/STAT signaling pathway in experimental diabetic rats
- (2016) Ayman Mahmoud et al. Drug Design Development and Therapy
- Sedentary Time and Its Association With Risk for Disease Incidence, Mortality, and Hospitalization in Adults
- (2015) Aviroop Biswas et al. ANNALS OF INTERNAL MEDICINE
- Monocytes from patients with rheumatoid arthritis and type 2 diabetes mellitus display an increased production of interleukin (IL)-1β via the nucleotide-binding domain and leucine-rich repeat containing family pyrin 3(NLRP3)-inflammasome activation: a pos
- (2015) P. Ruscitti et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Trends in Insulin Use and Diabetes Control in the U.S.: 1988–1994 and 1999–2012
- (2015) Elizabeth Selvin et al. DIABETES CARE
- Abatacept Improves Whole-Body Insulin Sensitivity in Rheumatoid Arthritis
- (2015) Francesco Ursini et al. MEDICINE
- Insulin Resistance in Rheumatoid Arthritis: Disease-Related Indicators and Associations With the Presence and Progression of Subclinical Atherosclerosis
- (2015) Jon T. Giles et al. Arthritis & Rheumatology
- Sarilumab Plus Methotrexate in Patients With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate: Results of a Phase III Study
- (2015) Mark C. Genovese et al. Arthritis & Rheumatology
- Effects of Tumour Necrosis Factor Antagonists on Insulin Sensitivity/Resistance in Rheumatoid Arthritis: A Systematic Review and Meta-Analysis
- (2015) Agata N. Burska et al. PLoS One
- Associations of Circulating Lymphocyte Subpopulations with Type 2 Diabetes: Cross-Sectional Results from the Multi-Ethnic Study of Atherosclerosis (MESA)
- (2015) Nels C. Olson et al. PLoS One
- Interrelated reduction of chemerin and plasminogen activator inhibitor-1 serum levels in rheumatoid arthritis after interleukin-6 receptor blockade
- (2014) Konstantinos Makrilakis et al. CLINICAL RHEUMATOLOGY
- Methotrexate in Rheumatoid Arthritis: Optimizing Therapy Among Different Formulations. Current and Emerging Paradigms
- (2014) Paola Cipriani et al. CLINICAL THERAPEUTICS
- Methotrexate: an old new drug in autoimmune disease
- (2014) Paola Cipriani et al. Expert Review of Clinical Immunology
- Adiponectin-leptin ratio: A useful estimate of insulin resistance in patients with Type 2 diabetes
- (2014) J. Zaletel et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Confounding by Indication Probably Distorts the Relationship between Steroid Use and Cardiovascular Disease in Rheumatoid Arthritis: Results from a Prospective Cohort Study
- (2014) Alper M. van Sijl et al. PLoS One
- Effect of Methotrexate Use and Erythrocyte Methotrexate Polyglutamate on Glycosylated Hemoglobin in Rheumatoid Arthritis
- (2014) Maurits C. F. J. de Rotte et al. Arthritis & Rheumatology
- Targeting gp130 to prevent inflammation and promote insulin action
- (2013) M. J. Kraakman et al. DIABETES OBESITY & METABOLISM
- Effects of Interleukin-1β Inhibition With Canakinumab on Hemoglobin A1c, Lipids, C-Reactive Protein, Interleukin-6, and Fibrinogen
- (2012) Paul M Ridker et al. CIRCULATION
- The Canadian Early Arthritis Cohort (CATCH): Patients with New-onset Synovitis Meeting the 2010 ACR/EULAR Classification Criteria But Not the 1987 ACR Classification Criteria Present with Less Severe Disease Activity
- (2012) V. P. BYKERK et al. JOURNAL OF RHEUMATOLOGY
- Topical insulin application improves healing by regulating the wound inflammatory response
- (2012) Xuelian Chen et al. WOUND REPAIR AND REGENERATION
- Anti-tumor necrosis factor therapy improves insulin resistance, beta cell function and insulin signaling in active rheumatoid arthritis patients with high insulin resistance
- (2012) Ilias Stagakis et al. ARTHRITIS RESEARCH & THERAPY
- Anti-tumour necrosis factor alpha therapy improves insulin sensitivity in normal-weight but not in obese patients with rheumatoid arthritis
- (2012) Antonios Stavropoulos-Kalinoglou et al. ARTHRITIS RESEARCH & THERAPY
- Do the treatment with glucocorticoids and/or the disease itself drive the impairment in glucose metabolism in patients with rheumatoid arthritis?
- (2011) F. Buttgereit ANNALS OF THE RHEUMATIC DISEASES
- Glucose tolerance, insulin sensitivity and -cell function in patients with rheumatoid arthritis treated with or without low-to-medium dose glucocorticoids
- (2011) J. N. Hoes et al. ANNALS OF THE RHEUMATIC DISEASES
- Metabolic effects of high-dose prednisolone treatment in early rheumatoid arthritis: Balance between diabetogenic effects and inflammation reduction
- (2011) Debby den Uyl et al. ARTHRITIS AND RHEUMATISM
- Systemic Blockade of TNF-α does not Improve Insulin Resistance in Humans
- (2011) I. Ferraz-Amaro et al. HORMONE AND METABOLIC RESEARCH
- Association Between Disease-Modifying Antirheumatic Drugs and Diabetes Risk in Patients With Rheumatoid Arthritis and Psoriasis
- (2011) Daniel H. Solomon JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies
- (2011) Daniel A Winer et al. NATURE MEDICINE
- The Pathogenesis of Rheumatoid Arthritis
- (2011) Iain B. McInnes et al. NEW ENGLAND JOURNAL OF MEDICINE
- Emerging roles of JAK–STAT signaling pathways in adipocytes
- (2011) Allison J. Richard et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Current evidence for the management of rheumatoid arthritis with glucocorticoids: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritis
- (2010) S. L. Gorter et al. ANNALS OF THE RHEUMATIC DISEASES
- Improvement of HbA1c during treatment with humanised anti-interleukin 6 receptor antibody, tocilizumab
- (2010) A. Ogata et al. ANNALS OF THE RHEUMATIC DISEASES
- Changes in glycosylated hemoglobin after initiation of hydroxychloroquine or methotrexate treatment in diabetes patients with rheumatic diseases
- (2010) Laura R. Rekedal et al. ARTHRITIS AND RHEUMATISM
- Incident Comorbidity Among Patients with Rheumatoid Arthritis Treated or Not with Low-dose Glucocorticoids: A Retrospective Study
- (2010) M. MAZZANTINI et al. JOURNAL OF RHEUMATOLOGY
- Rheumatoid arthritis
- (2010) David L Scott et al. LANCET
- Blockade of interleukin 1 in type 1 diabetes mellitus
- (2010) Thomas Mandrup-Poulsen et al. Nature Reviews Endocrinology
- Effects of Inhibition of Interleukin-6 Signalling on Insulin Sensitivity and Lipoprotein (A) Levels in Human Subjects with Rheumatoid Diseases
- (2010) Olaf Schultz et al. PLoS One
- Abatacept, a Novel CD80/86-CD28 T Cell Co-stimulation Modulator, in the Treatment of Rheumatoid Arthritis
- (2009) Riku Korhonen et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- Sustained Effects of Interleukin-1 Receptor Antagonist Treatment in Type 2 Diabetes
- (2009) C. M. Larsen et al. DIABETES CARE
- Osteoclasts and Arthritis
- (2009) Georg Schett et al. JOURNAL OF BONE AND MINERAL RESEARCH
- The role of interleukins in insulin resistance and type 2 diabetes mellitus
- (2009) Bruno Fève et al. Nature Reviews Endocrinology
- High Glucose Induces Toll-Like Receptor Expression in Human Monocytes: Mechanism of Activation
- (2008) M. R. Dasu et al. DIABETES
- Glucose metabolism in lymphocytes is a regulated process with significant effects on immune cell function and survival
- (2008) Nancie J. MacIver et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes
- (2008) Adilson Guilherme et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Interleukin-6 regulates pancreatic -cell mass expansion
- (2008) H. Ellingsgaard et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Prevalence of the metabolic syndrome is increased in rheumatoid arthritis and is associated with coronary atherosclerosis
- (2007) Cecilia P. Chung et al. ATHEROSCLEROSIS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started